0000000001087202

AUTHOR

Dario D'agostino

showing 1 related works from this author

Validation and refinement of PROSASH model using the neutrophil‐to‐lymphocyte ratio in patients with HCC receiving sorafenib

2020

Sorafenibmedicine.medical_specialtybusiness.industryPharmaceutical ScienceHepatitis Cmedicine.diseaseGastroenterologyComplementary and alternative medicineInternal medicinemedicinePharmacology (medical)In patientNeutrophil to lymphocyte ratioAlpha-fetoproteinbusinessmedicine.drugLiver Cancer International
researchProduct